Li et al reported the CoVID-TE score for predicting the risk of venous thromboembolism for a hospitalized patient with cancer and COVID-19. This can help to identify a patient who may require more aggressive management. The authors are from multiple institutions in the United States and Switzerland.
CoVID-TE is an acronym for cancer subtype, VTE history, ICU admission, D-dimer, therapy and ethnicity.
Parameters:
(1) cancer subtype by the original Khorana score
(2) history of venous thromboembolism (VTE)
(3) ICU admission
(4) D-dimer concentration
(5) recent systemic anti-cancer therapy
(6) ethnicity
Parameter
Findiing
Points
cancer subtype
high or very high risk
1
other
0
history of VTE
no
0
yes
2
ICU admission
no
0
yes
2
D-dimer
elevated
1
not elevated
0
recent chemotherapy
no
0
yes
1
ethnicity
Hispanic
0
non-Hispanic
1
total score =
= SUM(points for all of the parameters)
Interpretation:
• minimum score: 0
• maximum score: 8
• The patient is high risk if the score is >= 3.
• The risk of thromboembolism is 11.3% in the high-risk group and 4.1% in the low-risk group.
Performance:
• The area under the ROC curve is 0.67.
To read more or access our algorithms and calculators, please log in or register.
